In biopharmaceutical manufacturing, the trend is towards the production of new oncology products such as ADCs (Antibody Drug Conjugates) or in the field of regenerative medicine such as genes and immunotherapies. Most of these pharmaceutical products are combination products that also contain a highly active substance. These highly active substances require a new form of employee protection as well as higher requirements for cleaning when changing products.